Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

In Brief: AHCPR

  • News

Executive Summary

AHCPR: HHS' Eric Katz will join Agency for Health Care Policy & Research Office of the Administrator as senior policy advisor on April 3. Katz is senior policy analyst in the office of the Assistant Secretary for Health Phil Lee, MD. At AHCPR, Katz' responsibilities will include cost-effectiveness studies, outcomes research and clinical practice guidelines. For the last two years he has been involved with health care reform issues. Katz also evaluated drug pricing policy in Germany under a Fulbright grant and served as executive director of the Edwards Committee on FDA (1989-1991)...

Table

View full table

Tags:
Latest Headlines

Brand Drug Shortages Complicate US FDA Messaging To Congress

Relyvrio’s Failure Sparks NeuroSense ALS Development Changes

Pink Sheet Podcast: BIOSECURE Act Advances, Trial Diversity Sticks, Platform Principles Without Designation

FTC Is Taking A Tougher Stance On Pharma, A Deputy Director Explains Why

See All
UsernamePublicRestriction

Register

PS025953

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By